Sandell Scott D's Form 4 filing
Crescent Biopharma, Inc. (CBIO) · filed Jan 6, 2023
- Accession no.
- 0001209191-23-002468
- Filed
- Jan 6, 2023
- Trade date
- Jan 5, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $197.0K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sandell Scott DCIK 0001237289 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 5, 2023 | Common Stock | SSaleDisposed | −39,223 | $2.76 | −$108,255.48 | 4,737,613 | Indirect | |
| Jan 5, 2023 | Common Stock | SSaleDisposed | −32,139 | $2.76 | −$88,703.64 | 3,881,933 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.